Investor List:

Top Drug Delivery Series A Investors in Washington, D.C. (5)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Washington, D.C. (Other Lists), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
R. Jacob Vogelstein
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B)
Photo of Justin Hanes, Venture Partner at Catalio Capital
Justin Hanes
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Waltham (MA), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A)
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in AgTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Washington, D.C. (Other Lists), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Photo of Henry Brem, Venture Partner at Catalio Capital
Henry Brem
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Baltimore (MD)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A)
Get new data & insights delivered to your inbox
Firms investing in this space